Showing results (1-10 of 260) with videos related to
Sort By:
Pageof 26
Expert Review of Hematology|July 13, 2018
Pacritinib to treat myelofibrosis patients with thrombocytopeniaDouglas Tremblay, John MascarenhasExpert Opinion on Pharmacotherapy|March 16, 2023
Pharmacotherapeutic advances for splenomegaly in myelofibrosisDouglas Tremblay, John MascarenhasCurrent Hematologic Malignancy Reports|February 9, 2020
Novel Therapies in Polycythemia VeraDouglas Tremblay, John MascarenhasCells|April 30, 2021
Next Generation Therapeutics for the Treatment of MyelofibrosisDouglas Tremblay, John MascarenhasDrugs|August 10, 2017
Pharmacotherapy of MyelofibrosisDouglas Tremblay, Bridget Marcellino, John MascarenhasAnnals of Hematology|March 28, 2022
Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directionsHannah Goulart, John Mascarenhas, Douglas TremblayClinical Lymphoma, Myeloma & Leukemia|July 14, 2016
Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future DirectionsSheena Bhalla, Douglas Tremblay, John MascarenhasLeukemia & Lymphoma|November 30, 2023
Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and managementSerena Tharakan, John Mascarenhas, Douglas TremblayActa Haematologica|April 7, 2021
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic LymphohistiocytosisLeonard Naymagon, Douglas Tremblay, John MascarenhasEuropean Journal of Haematology|January 29, 2020
Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosisLeonard Naymagon, Douglas Tremblay, John MascarenhasPageof 26